NAUTILUS BIOTECHNOLOGY INC (NAUT) Fundamental Analysis & Valuation

NASDAQ:NAUT • US63909J1088

Current stock price

3.12 USD
-0.23 (-6.87%)
Last:

This NAUT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NAUT Profitability Analysis

1.1 Basic Checks

  • In the past year NAUT has reported negative net income.
  • NAUT had a negative operating cash flow in the past year.
  • NAUT had negative earnings in each of the past 5 years.
  • In the past 5 years NAUT always reported negative operating cash flow.
NAUT Yearly Net Income VS EBIT VS OCF VS FCFNAUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of NAUT (-30.87%) is worse than 78.95% of its industry peers.
  • NAUT's Return On Equity of -37.59% is on the low side compared to the rest of the industry. NAUT is outperformed by 64.91% of its industry peers.
Industry RankSector Rank
ROA -30.87%
ROE -37.59%
ROIC N/A
ROA(3y)-26.96%
ROA(5y)-22.01%
ROE(3y)-31.83%
ROE(5y)-25.55%
ROIC(3y)N/A
ROIC(5y)N/A
NAUT Yearly ROA, ROE, ROICNAUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40 -50

1.3 Margins

  • NAUT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAUT Yearly Profit, Operating, Gross MarginsNAUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. NAUT Health Analysis

2.1 Basic Checks

  • NAUT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for NAUT has been increased compared to 5 years ago.
  • NAUT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NAUT Yearly Shares OutstandingNAUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NAUT Yearly Total Debt VS Total AssetsNAUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 4.48 indicates that NAUT is not in any danger for bankruptcy at the moment.
  • NAUT's Altman-Z score of 4.48 is amongst the best of the industry. NAUT outperforms 82.46% of its industry peers.
  • NAUT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.48
ROIC/WACCN/A
WACCN/A
NAUT Yearly LT Debt VS Equity VS FCFNAUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • NAUT has a Current Ratio of 13.33. This indicates that NAUT is financially healthy and has no problem in meeting its short term obligations.
  • NAUT's Current ratio of 13.33 is amongst the best of the industry. NAUT outperforms 100.00% of its industry peers.
  • NAUT has a Quick Ratio of 13.33. This indicates that NAUT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 13.33, NAUT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.33
Quick Ratio 13.33
NAUT Yearly Current Assets VS Current LiabilitesNAUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NAUT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.07% over the past year.
EPS 1Y (TTM)16.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.37% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-19.36%
EPS Next 2Y-9.25%
EPS Next 3Y-1.37%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAUT Yearly Revenue VS EstimatesNAUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
NAUT Yearly EPS VS EstimatesNAUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. NAUT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NAUT. In the last year negative earnings were reported.
  • Also next year NAUT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAUT Price Earnings VS Forward Price EarningsNAUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAUT Per share dataNAUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.25%
EPS Next 3Y-1.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NAUT Dividend Analysis

5.1 Amount

  • NAUT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NAUT Fundamentals: All Metrics, Ratios and Statistics

NAUTILUS BIOTECHNOLOGY INC

NASDAQ:NAUT (4/7/2026, 12:44:05 PM)

3.12

-0.23 (-6.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-26
Earnings (Next)04-27
Inst Owners33.52%
Inst Owner Change0%
Ins Owners32.29%
Ins Owner Change0.01%
Market Cap394.87M
Revenue(TTM)N/A
Net Income(TTM)-59.00M
Analysts85
Price Target4.08 (30.77%)
Short Float %0.63%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.54%
Min EPS beat(2)22.97%
Max EPS beat(2)28.1%
EPS beat(4)4
Avg EPS beat(4)22.06%
Min EPS beat(4)13.06%
Max EPS beat(4)28.1%
EPS beat(8)8
Avg EPS beat(8)19.01%
EPS beat(12)12
Avg EPS beat(12)18.81%
EPS beat(16)16
Avg EPS beat(16)20.67%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)60%
PT rev (3m)60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.12%
EPS NY rev (1m)0%
EPS NY rev (3m)9.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-53.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.52
P/tB 2.52
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0
BVpS1.24
TBVpS1.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.87%
ROE -37.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.96%
ROA(5y)-22.01%
ROE(3y)-31.83%
ROE(5y)-25.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.85%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.33
Quick Ratio 13.33
Altman-Z 4.48
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)104.12%
Cap/Depr(5y)145.01%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
EPS Next Y-19.36%
EPS Next 2Y-9.25%
EPS Next 3Y-1.37%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-3.82%
EBIT Next 3Y-6.15%
EBIT Next 5Y2.76%
FCF growth 1Y15.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.29%
OCF growth 3YN/A
OCF growth 5YN/A

NAUTILUS BIOTECHNOLOGY INC / NAUT Fundamental Analysis FAQ

What is the fundamental rating for NAUT stock?

ChartMill assigns a fundamental rating of 2 / 10 to NAUT.


What is the valuation status for NAUT stock?

ChartMill assigns a valuation rating of 0 / 10 to NAUTILUS BIOTECHNOLOGY INC (NAUT). This can be considered as Overvalued.


What is the profitability of NAUT stock?

NAUTILUS BIOTECHNOLOGY INC (NAUT) has a profitability rating of 0 / 10.


What is the earnings growth outlook for NAUTILUS BIOTECHNOLOGY INC?

The Earnings per Share (EPS) of NAUTILUS BIOTECHNOLOGY INC (NAUT) is expected to decline by -19.36% in the next year.